Brisbane Clinical Trials
The Density Study
The study drug is a potential new treatment for osteoporosis.
2 + 2 x 1 nights
20 visits
Osteoporosis is a disease that is more common in women after menopause and it causes bones to become thin and weakened, which causes the bones to become fragile and fracture (break) easily.
There are currently treatments for osteoporosis available, but many of them have certain limitations. For example, the current most effective treatment for osteoporosis is a bone-forming medication called Evenity. While Evenity reduces the risk of fractures, its effects stop after 6 months and patients can only take the drug for 1 year.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Eligibility
Biological Sex Healthy post-menopausal or surgically sterile females
Age Male volunteers between 30-65 years old, female volunteers between 45-65 years old
BMI 18.5-32 kg/m2
Medication Certain medications may be permitted
Medical History No significant medical history, including no history of osteoporosis
Smoking History Non-smoker and casual smokers only (less than 3 cigarettes per day)